Drug Company

Apr 29, 2016 at 07:38 | Source: PTI
In a regulatory filing, Granules India said its Board of Directors today "approved further investment of USD 17.07 million (about Rs 117 crore) by way of debt/equity in Granules Pharmaceutical Inc, a wholly-owned foreign subsidiary of the company."
Apr 28, 2016 at 09:52 | Source: PTI
Citing a number of issues, including quality control, the US health regulator said it "may withhold approval of any new applications or supplements listing your firm as drug manufacturer" till corrections were made by the company which has been placed on import alert on September 11, 2015.
Apr 26, 2016 at 20:00 | Source: PTI
Biotechnology firm Biocon today said its product portfolio will not be affected by an order of the Delhi High Court that prevented the company from calling its breast cancer medicine Trastuzumab as a biosimilar of Roche's Herceptin.
Apr 26, 2016 at 15:14 | Source: PTI
NPPA has informed that during 2015-16, demand notices were issued to 263 companies amounting to Rs 928.32 crore, Minster of Chemicals & Fertilizers Ananth Kumar said in a reply in Lok Sabha.
Apr 26, 2016 at 15:04 | Source: Moneycontrol.com
The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Amlodipine and Valsartan Tablets USP, 5mg/160mg, 10mg/160mg, 5mg/320mg and 10mg/320mg.
Apr 26, 2016 at 11:24 | Source: PTI
Glenmark Pharmaceuticals USA has been granted tentative approval by the USFDA for Norethindrone Acetate and Ethinyl Estradiol tablets USP, 1 mg/0.01 mg, Ethinyl Estradiol tablets USP, 0.01 mg and Ferrous Fumarate tablets, 75 mg, the generic version of Lo Loestrin Fe, the company said in a BSE filing today.
Apr 25, 2016 at 15:51 | Source: Moneycontrol.com
Aarey Drugs & Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 04, 2016, to review the expansion of manufacturing facilities of the Company.
Apr 22, 2016 at 14:11 | Source: Moneycontrol.com
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Esomeprazole Magnesium delayed- release capsules USP, 20 mg and 40 mg.
Apr 22, 2016 at 13:48 | Source: PTI
"The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Esomeprazole Magnesium delayed release capsules USP, 20mg and 40 mg," Aurobindo Pharma said in a BSE filing.
Apr 22, 2016 at 11:21 | Source: Reuters
Although the world's biggest prescription drugmaker's first-quarter core net income fell 13 percent to USD 2.79 billion, it beat the USD 2.76 billion average of estimates from analysts polled by Reuters and lifted the company's shares.
Messages on Drug Company »


Gold Member


Dr Reddys Labs  

The US market continues to drive growth for Dr Reddy`s and other Indian generic drug companies. What if this paradigm changes in the global context? The US drives the growth but we have to diversify our sources of growth even though the relative importance of the US may not change. Emerging markets

8.53 PM Jun 30th 2014

anil patil

Platinum Member


Aurobindo Pharm  

deal details with the stock exchanges showed. Morgan Stanley Asia Singapore, which is a shareholder of Aurobindo Pharma, sold 17,32,500 shares of the drug company for about Rs 670 apiece, valuing the transaction at Rs 116 crore. Morgan Stanley Asia Singapore held 46.16 lakh shares of Aurobindo Pharma

11.48 AM May 31st 2014


Platinum Member


Dishman Pharma  

Dishman Pharma is likely to move to UC after 28.05.2014. This drug company will find support at Rs.125/- on account of excellent results. Your best time to pick up this stock at the bottom fishing zone.

8.43 PM May 26th 2014


New Member



Drug Policy Control Order (DPCO) put a cap on the prices of 348 essential drugs, is likely to impact domestic revenue generation of both homegrown and multinational drug companies in 2014

12.55 PM May 15th 2014


Platinum Member



, according to data tracker Dealogic. Many drug companies have paid down debt taken on during a buying spree in the earlier 2000s and are now generating lots of cash they want to put to work. Prescription drug makers are also attracted to acquisitions because deals can allow them cut costs and scale back

4.02 PM Apr 22nd 2014


New Member


Aurobindo Pharm  

...so buy , rather accumulate Auro even at current levels for a 1-2 year timeframe. these US legalities are nothing new to Indian drug companies,happens all the time !

10.06 AM Apr 17th 2014

Web Messenger

Platinum Member


Sun Pharma  

Source:VC Circle - Sun Pharmaceutical Industries Ltd, the country's top drugmaker by market cap, is acquiring Ranbaxy Laboratories Ltd in an all-stock transaction, creating the world's fifth-largest generics drug company and the largest pharma company in India by far

12.10 PM Apr 8th 2014


Platinum Member


Sun Pharma  

Is it patent dispute with Drug company UCB?

9.16 PM Mar 18th 2014


Gold Member


Vivimed Labs  

I am doctor by profession and knows the value of research and upcoming drugs. COMPANY has spent lot of rs in research and next quarter filing new ADNA / molecules which will drive the earning. you see almost 90% of shares are by institutes or large investor.

12.47 PM Mar 18th 2014

Web Messenger

Platinum Member



Source:Calcutta Telegraph News - Mumbai, Feb. 20: Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country. This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name

2.10 PM Feb 21st 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.